Related references
Note: Only part of the references are listed.Medicinal Chemistry Strategies to Disrupt the p53-MDM2/MDMX Interaction
Agostinho Lemos et al.
MEDICINAL RESEARCH REVIEWS (2016)
Laparoscopic adrenalectomy for adrenal tumors: A 21-year single-institution experience
Daisaku Hirano et al.
ASIAN JOURNAL OF SURGERY (2015)
Screening for primary aldosteronism in an argentinian population: a multicenter prospective study
Mariela Leal Reyna et al.
ARCHIVES OF ENDOCRINOLOGY METABOLISM (2015)
Transforming Growth Factor β1 (TGF-β1) Enhances Expression of Profibrotic Genes through a Novel Signaling Cascade and MicroRNAs in Renal Mesangial Cells
Nancy E. Castro et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Elastin and collagen fibre microstructure of the human aorta in ageing and disease: a review
Alkiviadis Tsamis et al.
JOURNAL OF THE ROYAL SOCIETY INTERFACE (2013)
Aortic Cell Apoptosis in Rat Primary Aldosteronism Model
Yongji Yan et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2010)
Factors Determining Cardiovascular and Renal Outcomes after Adrenalectomy in Patients with Aldosterone-Producing Adrenal Adenoma
Terry Ting-Yu Chiou et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2009)
A comparison of the aldosterone-blocking agents eplerenone and spironolactone
Allan Struthers et al.
CLINICAL CARDIOLOGY (2008)
p53: A guide to apoptosis
Erik Meulmeester et al.
CURRENT CANCER DRUG TARGETS (2008)
Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism
Giampaolo Bernini et al.
JOURNAL OF HYPERTENSION (2008)
Retroperitoneoscopic adrenalectomy without previous control of adrenal vein is feasible and safe for pheochromocytoma
Xu Zhang et al.
UROLOGY (2007)
Technique of anatomical retroperitoneoscopic adrenalectomy with report of 800 cases
Xu Zhang et al.
JOURNAL OF UROLOGY (2007)
Involvements of rho-kinase and TGF-β pathways in aldosterone-induced renal injury
Guang-Ping Sun et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
MDM2: A novel mineralocorticoid-responsive gene involved in aldosterone-induced human vascular structural remodeling
Yasuhiro Nakamura et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Changes in extracellular matrix in subcutaneous small resistance arteries of patients with primary aldosteronism
Damiano Rizzoni et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Mechanisms of mineralocorticoid action
PJ Fuller et al.
HYPERTENSION (2005)
Aldosterone stimulates vascular smooth muscle cell proliferation via big mitogen-activated protein kinase 1 activation
K Ishizawa et al.
HYPERTENSION (2005)
CRF receptor type 1 mediates continual hypoxia-induced CRF peptide and CRF mRNA expression increase in hypothalamic PVN of rats
JF Xu et al.
PEPTIDES (2005)
Extensive personal experience - Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents
P Mulatero et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Effect of aldosterone on renal transforming growth factor-β
I Juknevicius et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2004)
Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling
Q Pu et al.
HYPERTENSION (2003)
Increased carotid wall elastic modulus and fibronectin in aldosterone-salt-treated rats
P Lacolley et al.
CIRCULATION (2002)
Current role of laparoscopic adrenalectomy
G Guazzoni et al.
EUROPEAN UROLOGY (2001)
Share Paper
